PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
06-Dec-2022 MHRA approves Adtralza®▼(tralokinumab) for the treatment of adolescent patients with moderate-to-severe atopic dermatitis, who are candidates for systemic therapy LEO Pharma
06-Dec-2022 Exscientia Presents Novel Immuno-Oncology Biomarker for EXS-21546 at the ESMO I-O Annual Congress Exscientia
06-Dec-2022 Evonik launches plant-based squalene to boost vaccine efficacy Evonik
06-Dec-2022 Pumas-AI Hires Dr. Salim Bouchene and Expands Consulting Practice in Europe Pumas-AI
06-Dec-2022 Tiziana Life Sciences Announces Date of Annual General Meeting 2022 Tiziana Life Sciences
06-Dec-2022 Immutep announces GMP manufacturing process developed for IMP761, a first-in-class LAG-3 agonist for autoimmune disease Immutep
06-Dec-2022 Evaxion and ExpreS²ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate Evaxion Biotech
06-Dec-2022 Molecure Announces Details for Virtual R&D Day Webcast to be held on Wednesday 7th December 2022 Molecure
06-Dec-2022 Alfa Chemistry Diversifies Its Chemical Supply by Adding Luminescent Materials, Biomedical Polymers, and Electroplating Intermediates Alfa Chemistry
02-Dec-2022 Almirall joins FACILITATE, a patient-driven Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants Almirall
02-Dec-2022 VPM1002 Vaccination as Prophylaxis Against Severe Respiratory Infectious Diseases VPM1002 Vaccination as Prophylaxis Against Severe Respiratory Infectious Diseases
02-Dec-2022 Aptamer Group announces new deals to support novel therapies and improved assays Aptamer Group announces new deals to support novel therapies and improved assays
02-Dec-2022 Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors Immunocore
01-Dec-2022 Quest for health accelerator launches in French Grand Est region with focus on healthcare start-ups Andrew Lloyd Associates
01-Dec-2022 Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology Avectas
01-Dec-2022 Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process Creative Proteomics
01-Dec-2022 Creative Proteomics Lipidomics Launches Ceramides Analysis Service Creative Proteomics
01-Dec-2022 Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service Creative Proteomics
30-Nov-2022 Bayer receives acceptance of Kerendia® ▼ (finerenone) by Scottish Medicines Consortium (SMC) for treating adult patients with chronic kidney disease associated with type 2 diabetes in NHS Scotland Bayer
29-Nov-2022 BioWin expands its ‘Growth & Financing’ member service by appointing two industry experts Andrew Lloyd Associates